Prism marketview features q&a with dr. michael chancellor: lipella pharmaceuticals advances innovative treatments for hemorrhagic cystitis during urology awareness month

New york, sept. 25, 2024 (globe newswire) -- prism marketview presents an exclusive q&a with dr. michael chancellor, co-founder and chief medical officer of lipella pharmaceuticals, inc. (nasdaq: lipo).

LIPO Ratings Summary

LIPO Quant Ranking